항암 활성을 갖는 신규 제리쿠드라닌 이 및 제이 화합물, 및 그의 제조방법
    11.
    发明公开
    항암 활성을 갖는 신규 제리쿠드라닌 이 및 제이 화합물, 및 그의 제조방법 失效
    新型的枣皮苷和/或具有抗癌活性的化合物及其制备方法

    公开(公告)号:KR1019950031096A

    公开(公告)日:1995-12-18

    申请号:KR1019940009765

    申请日:1994-05-04

    Abstract: 본 발명은 암세포에 대해 매우 높은 항함 활성을 나타내는 신규 플라보노이드계 항함물질인 제리쿠드라닌이(E) 및 제이(J)화합물, 이를 유효성분으로 함유하는 약학 조성물 및 상기 화합물의 제조방법에 관한 것이다. 본 발명의 제리쿠드라닌 이(E) 및 제이(J)화합물은 꾸지 뽕나무 추출액으로부터 분리, 정제과정을 거쳐 수득할 수 있는 신규 물질로서, 신장암 세포, 유방암 세포, 혈액암 세포, 전립선암 세포, 폐암 세포, 간암 세포, 대장암 세포, 피부암 세포, 자궁암 세포, 중추 신경계암 세포 등을 비롯한 암 세포에 대해 강한 항암활성을 나타내어 암 치료에 매우 유용한 플라보노이드계 천연물 유래 항암 물질이다.

    세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신

    公开(公告)号:KR100252197B1

    公开(公告)日:2000-04-15

    申请号:KR1019970047869

    申请日:1997-09-20

    CPC classification number: C12R1/43 C12P17/165

    Abstract: PURPOSE: Provided is prodigiosin isolated from culture broth of Serratia marcescens. The prodigiosin inhibits specifically immunogenecity of T cell and is used in immunosuppresive drug. CONSTITUTION: A Prodigiosin isolated from culture broth of Serratia marcescens B-1231 (KCTC 0386BP) is represented by the formula (I). The Prodigiosin is prepared by the following steps of: (a) cultivating Serratia marcescens B-1231 (KCTC 0386BP) in a medium comprised of soluble starch of 1%, glucose of 0.25, ammonium sulfate of 0.1%, potassium phosphate of 0.1%, magnesium sulfate- septuple crystal solution of 0.05%, calcium chloride of 0.1 %, sodium chloride of 0.3% at pH value of 7 and temperature of 28 deg.C for 62 hours; (b) mixing them with adding ethyl acetate in a same amount, thereto for 30 minutes, to obtain organic solvent layer; (c) concentrating the mixture under reduced pressure, to obtain a red material; (d) isolating and purifying an active material therefrom; and (e) purifying it by silicagel thin layer chromatography.

    Abstract translation: 目的:提供从粘质沙雷氏菌的培养液中分离的天蛾素。 胎牛血清抑制T细胞的特异性免疫原性,并用于免疫抑制药物。 构成:从粘质沙雷氏菌B-1231(KCTC 0386BP)的培养肉汤中分离出的地高辛分子由式(I)表示。 Prodigiosin通过以下步骤制备:(a)在由1%的可溶性淀粉,0.25的硫酸铵,0.1%的磷酸钾,0.1%的磷酸钾组成的培养基中培养粘质沙雷氏菌B-1231(KCTC 0386BP) 0.5%硫酸镁 - 六分体晶体溶液,氯化钙0.1%,氯化钠0.3%,pH值7,温度28℃62小时; (b)将其与相同量的乙酸乙酯混合30分钟,得到有机溶剂层; (c)在减压下浓缩混合物,得到红色材料; (d)从其中分离和纯化活性物质; 和(e)通过硅胶薄层色谱纯化。

    항암활성을가지는황칠나무추출물
    17.
    发明授权
    항암활성을가지는황칠나무추출물 失效
    鱼腥草提取物具有抗癌活性

    公开(公告)号:KR100318019B1

    公开(公告)日:2002-07-03

    申请号:KR1019980025942

    申请日:1998-06-30

    Abstract: 본 발명은 항암 및 항산화활성을 가지는 황칠나무 추출물에 관한 것으로서, 보다 상세하게는 우리나라에서 유일하게 생산되는 천연 도료 황칠의 원료인 황칠나무 (
    Dendropanax morbifera Lev) 또는 그 수액을 저급 알코올로 추출하고 다시 핵산, 에틸아세테이트 및 부탄올 등을 사용하여 순차적으로 분획한 황칠나무 추출물로 구성되며, 상기 추출물은 탁월한 항암활성에 더하여 항산화활성도 나타내므로 기능성 건강식품으로 유용하게 사용될 수 있다.

    참당귀에서분리한신규한펙틴질다당류와그분리정제방법및그의면역증강제로서의용도
    18.
    发明授权
    참당귀에서분리한신규한펙틴질다당류와그분리정제방법및그의면역증강제로서의용도 有权
    来自天竺葵的新型PECTIN型多糖,净化过程及其免疫学应用

    公开(公告)号:KR100252194B1

    公开(公告)日:2000-04-15

    申请号:KR1019970051930

    申请日:1997-10-10

    CPC classification number: C08B37/0045 A61K31/715 C08B37/00

    Abstract: PURPOSE: A novel pectin polysaccharides(Angellan-I, Angellan-II) separated from Angelica gigas Nakai is provided, which contains galacturonic acid, arabinose and galactose, therefore shows immune-increasing effect and also can be used as an immune-increasing reagent in the basic study for immunology. CONSTITUTION: A process for the separation of novel pectin polysaccharides(Angellan-I, Angellan-II) from Angelica gigas Nakai comprises the steps of: pulverizing Angelica gigas Nakai root into pieces, adding water and extracting while circulating at 100deg.C for 1hr; adding 3times of ethanol to the residual solution, leaving at 4deg.C for 3hrs and centrifuging to get extracted precipitates; dissolving the ethanol extract in water to remove impurities, adding 3times of ethanol to the residual solution again, centrifuging and processing dialysis; freeze-drying the reagent to get crude polysaccharides; and separating the crude polysaccharides into acidic polysaccharides(Angellan I) and neutral polysaccharides(Angellan II) by dissolving, washing, centrifuging, doing dialysis and freeze-drying.

    Abstract translation: 目的:提供从当归纳西分离的新型果胶多糖(Angellan-I,Angellan-II),其含有半乳糖醛酸,阿拉伯糖和半乳糖,因此具有免疫增加作用,并且还可用作免疫增加试剂 免疫学的基础研究。 构成:从当归Nakai中分离出新型果胶多糖(Angellan-I,Angellan-II)的方法,包括以下步骤:将当归Nakai根粉碎成片,加水并在100℃循环提取1小时; 向剩余溶液中加入3倍的乙醇,在4℃下放置3h,离心得到提取的沉淀物; 将乙醇提取液溶解于水中去除杂质,再次向剩余溶液中加入3倍乙醇,离心和加工透析液; 冷冻干燥试剂得到粗多糖; 并通过溶解,洗涤,离心,进行透析和冷冻干燥将粗多糖分离成酸性多糖(Angellan I)和中性多糖(Angellan II)。

    항암활성을가지는황칠나무추출물
    19.
    发明公开
    항암활성을가지는황칠나무추출물 失效
    DENDROPANAX MORBIFERA LEV提取物具有抗癌活性

    公开(公告)号:KR1020000004499A

    公开(公告)日:2000-01-25

    申请号:KR1019980025942

    申请日:1998-06-30

    Abstract: PURPOSE: An extract of Dendropanax Morbifera Lev extracted with a lower alcohol and fractioned with hexane, ethyl acetate and butanol is useful as an anti-oxidation and anti-cancer agent and applicable to functional medicine, food additives, beverage additives and health foods. CONSTITUTION: The sap or bark of Dendropanax Morbifera Lev is extracted with methanol and fractioned sequentially with organic solvents such as hexane, ethyl acetate and butanol. The hexane or ethyl acetate fraction of the Dendropanax Morbifera Lev is dissolved in toluene and then fractioned by silica gel column chromatography, ODS intermediate pressure column chromatography or cepadex column chromatography to obtain an extract of Dendropanax Morbifera Lev having anti-oxidation and anti-cancer ativities.

    Abstract translation: 目的:用低级醇提取Dendropanax Morbifera Lev的提取物,用己烷,乙酸乙酯和丁醇分级,可用作抗氧化和抗癌剂,适用于功能性药物,食品添加剂,饮料添加剂和保健食品。 构成:用甲醇提取Dendropanax Morbifera Lev的树皮或树皮,并依次用己烷,乙酸乙酯和丁醇等有机溶剂分级。 将Dendropanax Morbifera Lev的己烷或乙酸乙酯部分溶解在甲苯中,然后通过硅胶柱色谱,ODS中压柱层析或Cepadex柱色谱法分级,得到具有抗氧化和抗癌活性的Dendropanax Morbifera Lev的提取物 。

Patent Agency Ranking